Nonetheless, the [anti-E Abs] thus measured, demonstrating higher concentrations in secondary DENV infections as compared to primary infections, is in agreement with previous reports using other methods such as the plaque reduction neutralization test and endpoint dilution determined by ELISA [9], [15], [52]. The gene discussed is DDX41; the disease is infection.